Efficiency and pregnancy outcome of serial intrauterine device-guided hysteroscopic adhesiolysis of intrauterine synechiae

Fertil Steril. 2008 Nov;90(5):1973-7. doi: 10.1016/j.fertnstert.2007.06.074. Epub 2008 Sep 6.

Abstract

Objective: To highlight the efficiency of intrauterine device (IUD) guidance during hysteroscopic adhesiolysis for severe intrauterine adhesions.

Design: A prospective, randomized trial.

Setting: Private tertiary and referral infertility clinic.

Patient(s): Seventy-one subfertile patients who underwent hysteroscopic treatment of intrauterine synechiae or adhesions.

Intervention(s): Thirty-six women in group 1 were initially examined by laparoscopy-hysteroscopy at first look, and an IUD was inserted during hysteroscopic adhesiolysis. The adhesions were further lysed by the guidance of IUD during the second-look office hysteroscopy, 1 week later. Patients were prescribed 2 months of estrogen as well as P therapy, and the IUD was removed by the end of this period. The uterine cavity was evaluated, and adhesions were further lysed by a third-look office hysteroscopy, 1 week after the removal of IUD. Thirty-five women in group 2 were similarly examined by first-look office hysteroscopy, and an IUD was inserted during hysteroscopic adhesiolysis. These patients did not undergo early intervention of office hysteroscopy, 1 week after the first procedure. They also used 2 months of estrogen and P therapy. The IUD was removed by the end of this period, and the uterine cavity was evaluated and adhesions were further lysed during a second-look office hysteroscopy.

Main outcome measure(s): Pregnancy rate and live birth rate.

Result(s): Spontaneous pregnancy rates after treatment were 17/36 (47.2%) and 11/35 (30%), and live birth rates were 10/36 (28%) and 7/35 (20%) in groups 1 and 2, respectively. These differences between the two groups were not statistically significant.

Conclusion(s): The method described especially for early intervention may prevent complications during the treatment of severe intrauterine adhesions and may present a secure and effective alternative for constructive clinical outcomes.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Estrogens / administration & dosage
  • Estrogens, Conjugated (USP) / administration & dosage
  • Female
  • Fertilization in Vitro
  • Humans
  • Hysteroscopy* / adverse effects
  • Infertility, Female / drug therapy
  • Infertility, Female / etiology*
  • Infertility, Female / pathology
  • Infertility, Female / surgery
  • Intrauterine Devices*
  • Laparoscopy* / adverse effects
  • Live Birth
  • Medroxyprogesterone Acetate / administration & dosage
  • Pregnancy
  • Pregnancy Rate
  • Progestins / administration & dosage
  • Prospective Studies
  • Time Factors
  • Tissue Adhesions
  • Treatment Outcome
  • Uterine Diseases / complications
  • Uterine Diseases / drug therapy
  • Uterine Diseases / pathology
  • Uterine Diseases / surgery*

Substances

  • Estrogens
  • Estrogens, Conjugated (USP)
  • Progestins
  • Medroxyprogesterone Acetate